Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival

Table 5

Drug regimen received and number of cycles completed by treatment status.

	Began chemotherapy; 𝑁 (%)^1	Dose reduction; 𝑁 (%)^2	Incomplete chemotherapy cycles; 𝑁 (%)^2
Total	117 (100)	40 (34)	56 (48)
Drug regimen		𝑃 = 0.13^3	𝑃 = 0.05^3
Carboplatin/etoposide	55 (47)	24 (44)	27 (49)
Cisplatin/etoposide	36 (31)	11 (31)	12 (33)
oposide	25 (21)	5 (20)	16 (64)
CAV	1 (1)	0 (0)	1 (100)
Numbers of cycles completed
1	30 (26)	6 (20)
2	12 (10)	4 (33)
3	14 (12)	5 (36)
4+^4	61 (52)	25 (41)

1Column percentage.
²Row percentage: denominator is the number who began chemotherapy in corresponding row.
³𝑃 values based on Fisher’s exact test.
⁴Defined as completed chemotherapy cycles.